Security Snapshot

Inogen Inc - Common Stock (INGN) Institutional Ownership

CUSIP: 45780L104

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

124

Shares (Excl. Options)

18,978,840

Price

$6.18

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock
Symbol
INGN on Nasdaq
Shares outstanding
26,732,016
Price per share
$6.18
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
18,978,840
Total reported value
$117,280,071
% of total 13F portfolios
0%
Share change
+156,451
Value change
+$289,118
Number of holders
124
Price from insider filings
$6.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • INGN - Inogen Inc - Common Stock is tracked under CUSIP 45780L104.
  • 124 institutions reported positions in Q1 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 131 to 124 between Q4 2025 and Q1 2026.
  • Reported value moved from $126,491,546 to $117,280,071.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 124 institutions filings for Q1 2026.

Open SEC Evidence

Security key

45780L104

Latest holder period

Q1 2026

13F holders

124

13D/G owners

3

CIK / CUSIP context first

Open Q1 2026 holders INGN full holder history Inogen Inc SEC filings Inogen Inc company facts Inogen Inc insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of Inogen Inc - Common Stock (INGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Yuwell (Hong Kong) Holdings Ltd 9.9% $19,094,110 2,626,425 Yuwell (Hong Kong) Holdings Limited 21 Feb 2025
BlackRock, Inc. 6.2% $11,651,417 1,657,385 BlackRock, Inc. 30 Jun 2025
Camber Capital Management LP 3.7% $7,088,250 975,000 Camber Capital Management LP 31 Mar 2025

As of 31 Mar 2026, 124 institutional investors reported holding 18,978,840 shares of Inogen Inc - Common Stock (INGN). This represents 71% of the company’s total 26,732,016 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Inogen Inc - Common Stock (INGN) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 6.2% 1,647,084 -4.1% 0% $10,178,979
ARMISTICE CAPITAL, LLC 4.5% 1,200,000 -5.1% 0.24% $7,416,000
ACADIAN ASSET MANAGEMENT LLC 4.1% 1,083,483 0% 0.01% $6,692,000
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 1,036,705 0% 0% $6,406,837
AMERIPRISE FINANCIAL INC 3.2% 859,543 -0.12% 0% $5,311,976
DAFNA Capital Management LLC 3.2% 845,179 +2.2% 1.2% $5,223,206
Point72 Asset Management, L.P. 2.4% 642,366 +218% 0.01% $3,969,822
GEODE CAPITAL MANAGEMENT, LLC 2.3% 613,529 +2.4% 0% $3,792,541
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2.2% 586,159 +204% 0% $3,622,463
GOLDMAN SACHS GROUP INC 2.2% 580,100 -1.6% 0% $3,585,018
STATE STREET CORP 2.1% 573,204 +12% 0% $3,542,401
MORGAN STANLEY 2% 541,164 -3.1% 0% $3,344,399
FEDERATED HERMES, INC. 1.9% 514,656 +6% 0.01% $3,180,574
DIMENSIONAL FUND ADVISORS LP 1.9% 509,822 -28% 0% $3,150,666
RENAISSANCE TECHNOLOGIES LLC 1.8% 478,800 -18% 0% $2,958,984
JPMORGAN CHASE & CO 1.6% 427,656 -8.9% 0% $2,612,978
AQR CAPITAL MANAGEMENT LLC 1.6% 427,118 +90% 0% $2,639,589
CSM Advisors, LLC 1.5% 413,880 -0.51% 0.06% $2,557,000
PRUDENTIAL FINANCIAL INC 1.4% 369,070 -19% 0% $2,280,853
Nuveen, LLC 1.4% 363,682 -12% 0% $2,247,555
ExodusPoint Capital Management, LP 1.2% 330,441 0.02% $2,042,125
JACOBS LEVY EQUITY MANAGEMENT, INC 1.1% 296,969 +4.2% 0.01% $1,835,268
MOORE CAPITAL MANAGEMENT, LP 1% 279,899 +40% 0.06% $1,729,776
Peapod Lane Capital LLC 0.97% 258,645 1.3% $1,594,718
Qube Research & Technologies Ltd 0.91% 242,157 -7.9% 0% $1,496,530

Institutional Holders of Inogen Inc - Common Stock (INGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 18,978,840 $117,280,071 +$289,118 $6.18 124
2025 Q4 18,823,387 $126,491,546 +$6,315,193 $6.72 131
2025 Q3 18,455,951 $150,786,948 -$2,657,869 $8.17 129
2025 Q2 19,688,623 $138,418,602 +$6,364,370 $7.03 124
2025 Q1 18,787,521 $133,935,693 -$14,669,071 $7.13 126
2024 Q4 20,087,634 $184,201,707 -$1,057,602 $9.17 134
2024 Q3 20,267,563 $196,583,467 -$15,099,193 $9.70 132
2024 Q2 21,699,685 $176,312,057 +$2,481,739 $8.13 127
2024 Q1 21,319,353 $172,039,656 +$5,434,607 $8.07 126
2023 Q4 20,963,480 $115,089,732 +$1,084,598 $5.49 126
2023 Q3 21,134,316 $110,321,601 -$8,733,113 $5.22 125
2023 Q2 21,260,866 $245,629,305 -$14,332,634 $11.55 137
2023 Q1 22,403,661 $279,617,404 +$2,776,887 $12.48 147
2022 Q4 21,537,198 $424,532,972 -$13,967,541 $19.71 131
2022 Q3 22,156,698 $537,890,237 -$6,890,786 $24.28 135
2022 Q2 22,400,258 $541,728,575 -$4,379,455 $24.18 128
2022 Q1 21,981,812 $712,618,572 +$8,805,344 $32.42 141
2021 Q4 21,822,086 $741,863,302 -$18,203,866 $34.00 162
2021 Q3 21,449,032 $924,256,431 +$10,935,033 $43.09 164
2021 Q2 20,999,315 $1,368,450,907 +$9,613,816 $65.17 175
2021 Q1 20,828,208 $1,093,836,357 +$2,977,960 $52.52 152
2020 Q4 20,932,049 $935,306,890 -$23,064,970 $44.68 156
2020 Q3 21,577,449 $625,722,512 -$36,910,952 $29.00 144
2020 Q2 22,754,494 $808,210,454 -$4,758,324 $35.52 159
2020 Q1 22,668,162 $1,170,970,258 -$44,046,841 $51.66 175
2019 Q4 23,256,012 $1,588,580,933 -$57,296,938 $68.33 186
2019 Q3 24,192,208 $1,159,082,562 -$27,003,666 $47.91 169
2019 Q2 24,143,236 $1,608,962,739 -$89,011,992 $66.76 191
2019 Q1 24,891,285 $2,373,382,062 +$99,408,107 $95.37 229
2018 Q4 23,561,183 $2,925,726,937 +$102,273,022 $124.17 264
2018 Q3 21,463,232 $5,238,829,562 +$108,218,492 $244.12 275
2018 Q2 21,047,771 $3,922,403,080 +$4,687,171 $186.33 232
2018 Q1 21,074,251 $2,589,144,177 -$6,936,920 $122.84 222
2017 Q4 21,010,596 $2,502,216,554 -$38,315,698 $119.08 216
2017 Q3 21,389,851 $2,034,228,334 +$31,962,529 $95.10 207
2017 Q2 21,088,819 $2,012,222,315 +$30,871,972 $95.42 197
2017 Q1 20,894,372 $1,612,365,056 +$123,710,084 $77.56 192
2016 Q4 21,068,653 $1,415,149,459 -$82,395,633 $67.17 186
2016 Q3 22,310,907 $1,335,636,618 +$24,879,355 $59.90 171
2016 Q2 21,608,081 $1,082,889,346 +$23,531,430 $50.11 166
2016 Q1 21,200,067 $953,029,323 +$45,530,641 $44.98 171
2015 Q4 20,266,452 $812,578,180 +$35,954,763 $40.09 168
2015 Q3 19,059,472 $925,338,059 +$67,126,902 $48.55 157
2015 Q2 17,794,140 $793,607,428 +$69,912,694 $44.60 129
2015 Q1 16,419,024 $528,336,844 +$74,725,704 $31.99 107
2014 Q4 13,813,279 $433,338,855 +$78,148,367 $31.37 92
2014 Q3 11,099,929 $228,719,290 +$26,686,975 $20.61 62
2014 Q2 9,746,057 $219,870,374 +$10,915,231 $22.56 51
2014 Q1 9,358,761 $154,513,000 +$154,513,103 $16.51 44
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .